Acute kidney injury is associated with impaired cognition and chronic kidney disease in a prospective cohort of children with severe malaria

Andrea L. Conroy, Robert O. Opoka, Paul Bangirana, Richard Idro, John M. Ssenkusu, Dibyadyuti Datta, James S. Hodges, Catherine Morgan, Chandy John

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Acute kidney injury (AKI) is a recognized complication of pediatric severe malaria, but its long-term consequences are unknown. METHODS: Ugandan children with cerebral malaria (CM, n = 260) and severe malaria anemia (SMA, n = 219) or community children (CC, n = 173) between 1.5 and 12 years of age were enrolled in a prospective cohort study. Kidney Disease: Improving Global Outcomes (KDIGO) criteria were used to retrospectively define AKI and chronic kidney disease (CKD). Cognitive testing was conducted using the Mullen Scales of Early Learning in children < 5 and Kaufman Assessment Battery for Children (K-ABC) second edition in children ≥ 5 years of age. RESULTS: The prevalence of AKI was 35.1%, ranging from 25.1% in SMA to 43.5% in CM. In-hospital mortality was 11.9% in AKI compared to 4.2% in children without AKI (p = 0.001), and post-discharge mortality was 4.7% in AKI compared to 1.3% in children without AKI (p = 0.030) corresponding to an all-cause adjusted hazard ratio of 2.30 (95% CI 1.21, 4.35). AKI was a risk factor for short- and long-term neurocognitive impairment. At 1 week post-discharge, the frequency of neurocognitive impairment was 37.3% in AKI compared to 13.5% in children without AKI (adjusted odds ratio (aOR) 2.31 [95% CI 1.32, 4.04]); at 1-year follow-up, it was 13.3% in AKI compared to 3.4% in children without AKI (aOR 2.48 [95% CI 1.01, 6.10]), and at 2-year follow-up, it was 13.0% in AKI compared to 3.4% in children without AKI (aOR 3.03 [95% CI 1.22, 7.58]). AKI was a risk factor for CKD at 1-year follow-up: 7.6% of children with severe malaria-associated AKI had CKD at follow-up compared to 2.8% of children without AKI (p = 0.038) corresponding to an OR of 2.81 (95% CI 1.02, 7.73). The presenting etiology of AKI was consistent with prerenal azotemia, and lactate dehydrogenase as a marker of intravascular hemolysis was an independent risk factor for AKI in CM and SMA (p < 0.0001). In CM, AKI was associated with the presence and severity of retinopathy (p < 0.05) and increased cerebrospinal fluid albumin suggestive of blood-brain barrier disruption. CONCLUSIONS: AKI is a risk factor for long-term neurocognitive impairment and CKD in pediatric severe malaria.

Original languageEnglish (US)
Number of pages1
JournalBMC medicine
Volume17
Issue number1
DOIs
StatePublished - May 21 2019

Fingerprint

Chronic Renal Insufficiency
Acute Kidney Injury
Cognition
Malaria
Odds Ratio
Pediatrics
Cerebral Malaria
Azotemia
Kidney Diseases

Keywords

  • Acute kidney injury
  • Child
  • Chronic kidney disease
  • Cognition
  • Malaria
  • Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Acute kidney injury is associated with impaired cognition and chronic kidney disease in a prospective cohort of children with severe malaria. / Conroy, Andrea L.; Opoka, Robert O.; Bangirana, Paul; Idro, Richard; Ssenkusu, John M.; Datta, Dibyadyuti; Hodges, James S.; Morgan, Catherine; John, Chandy.

In: BMC medicine, Vol. 17, No. 1, 21.05.2019.

Research output: Contribution to journalArticle

Conroy, Andrea L. ; Opoka, Robert O. ; Bangirana, Paul ; Idro, Richard ; Ssenkusu, John M. ; Datta, Dibyadyuti ; Hodges, James S. ; Morgan, Catherine ; John, Chandy. / Acute kidney injury is associated with impaired cognition and chronic kidney disease in a prospective cohort of children with severe malaria. In: BMC medicine. 2019 ; Vol. 17, No. 1.
@article{85f00e1a56a74c8ca0433e0e0a8dcd70,
title = "Acute kidney injury is associated with impaired cognition and chronic kidney disease in a prospective cohort of children with severe malaria",
abstract = "BACKGROUND: Acute kidney injury (AKI) is a recognized complication of pediatric severe malaria, but its long-term consequences are unknown. METHODS: Ugandan children with cerebral malaria (CM, n = 260) and severe malaria anemia (SMA, n = 219) or community children (CC, n = 173) between 1.5 and 12 years of age were enrolled in a prospective cohort study. Kidney Disease: Improving Global Outcomes (KDIGO) criteria were used to retrospectively define AKI and chronic kidney disease (CKD). Cognitive testing was conducted using the Mullen Scales of Early Learning in children < 5 and Kaufman Assessment Battery for Children (K-ABC) second edition in children ≥ 5 years of age. RESULTS: The prevalence of AKI was 35.1{\%}, ranging from 25.1{\%} in SMA to 43.5{\%} in CM. In-hospital mortality was 11.9{\%} in AKI compared to 4.2{\%} in children without AKI (p = 0.001), and post-discharge mortality was 4.7{\%} in AKI compared to 1.3{\%} in children without AKI (p = 0.030) corresponding to an all-cause adjusted hazard ratio of 2.30 (95{\%} CI 1.21, 4.35). AKI was a risk factor for short- and long-term neurocognitive impairment. At 1 week post-discharge, the frequency of neurocognitive impairment was 37.3{\%} in AKI compared to 13.5{\%} in children without AKI (adjusted odds ratio (aOR) 2.31 [95{\%} CI 1.32, 4.04]); at 1-year follow-up, it was 13.3{\%} in AKI compared to 3.4{\%} in children without AKI (aOR 2.48 [95{\%} CI 1.01, 6.10]), and at 2-year follow-up, it was 13.0{\%} in AKI compared to 3.4{\%} in children without AKI (aOR 3.03 [95{\%} CI 1.22, 7.58]). AKI was a risk factor for CKD at 1-year follow-up: 7.6{\%} of children with severe malaria-associated AKI had CKD at follow-up compared to 2.8{\%} of children without AKI (p = 0.038) corresponding to an OR of 2.81 (95{\%} CI 1.02, 7.73). The presenting etiology of AKI was consistent with prerenal azotemia, and lactate dehydrogenase as a marker of intravascular hemolysis was an independent risk factor for AKI in CM and SMA (p < 0.0001). In CM, AKI was associated with the presence and severity of retinopathy (p < 0.05) and increased cerebrospinal fluid albumin suggestive of blood-brain barrier disruption. CONCLUSIONS: AKI is a risk factor for long-term neurocognitive impairment and CKD in pediatric severe malaria.",
keywords = "Acute kidney injury, Child, Chronic kidney disease, Cognition, Malaria, Mortality",
author = "Conroy, {Andrea L.} and Opoka, {Robert O.} and Paul Bangirana and Richard Idro and Ssenkusu, {John M.} and Dibyadyuti Datta and Hodges, {James S.} and Catherine Morgan and Chandy John",
year = "2019",
month = "5",
day = "21",
doi = "10.1186/s12916-019-1332-7",
language = "English (US)",
volume = "17",
journal = "BMC Medicine",
issn = "1741-7015",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Acute kidney injury is associated with impaired cognition and chronic kidney disease in a prospective cohort of children with severe malaria

AU - Conroy, Andrea L.

AU - Opoka, Robert O.

AU - Bangirana, Paul

AU - Idro, Richard

AU - Ssenkusu, John M.

AU - Datta, Dibyadyuti

AU - Hodges, James S.

AU - Morgan, Catherine

AU - John, Chandy

PY - 2019/5/21

Y1 - 2019/5/21

N2 - BACKGROUND: Acute kidney injury (AKI) is a recognized complication of pediatric severe malaria, but its long-term consequences are unknown. METHODS: Ugandan children with cerebral malaria (CM, n = 260) and severe malaria anemia (SMA, n = 219) or community children (CC, n = 173) between 1.5 and 12 years of age were enrolled in a prospective cohort study. Kidney Disease: Improving Global Outcomes (KDIGO) criteria were used to retrospectively define AKI and chronic kidney disease (CKD). Cognitive testing was conducted using the Mullen Scales of Early Learning in children < 5 and Kaufman Assessment Battery for Children (K-ABC) second edition in children ≥ 5 years of age. RESULTS: The prevalence of AKI was 35.1%, ranging from 25.1% in SMA to 43.5% in CM. In-hospital mortality was 11.9% in AKI compared to 4.2% in children without AKI (p = 0.001), and post-discharge mortality was 4.7% in AKI compared to 1.3% in children without AKI (p = 0.030) corresponding to an all-cause adjusted hazard ratio of 2.30 (95% CI 1.21, 4.35). AKI was a risk factor for short- and long-term neurocognitive impairment. At 1 week post-discharge, the frequency of neurocognitive impairment was 37.3% in AKI compared to 13.5% in children without AKI (adjusted odds ratio (aOR) 2.31 [95% CI 1.32, 4.04]); at 1-year follow-up, it was 13.3% in AKI compared to 3.4% in children without AKI (aOR 2.48 [95% CI 1.01, 6.10]), and at 2-year follow-up, it was 13.0% in AKI compared to 3.4% in children without AKI (aOR 3.03 [95% CI 1.22, 7.58]). AKI was a risk factor for CKD at 1-year follow-up: 7.6% of children with severe malaria-associated AKI had CKD at follow-up compared to 2.8% of children without AKI (p = 0.038) corresponding to an OR of 2.81 (95% CI 1.02, 7.73). The presenting etiology of AKI was consistent with prerenal azotemia, and lactate dehydrogenase as a marker of intravascular hemolysis was an independent risk factor for AKI in CM and SMA (p < 0.0001). In CM, AKI was associated with the presence and severity of retinopathy (p < 0.05) and increased cerebrospinal fluid albumin suggestive of blood-brain barrier disruption. CONCLUSIONS: AKI is a risk factor for long-term neurocognitive impairment and CKD in pediatric severe malaria.

AB - BACKGROUND: Acute kidney injury (AKI) is a recognized complication of pediatric severe malaria, but its long-term consequences are unknown. METHODS: Ugandan children with cerebral malaria (CM, n = 260) and severe malaria anemia (SMA, n = 219) or community children (CC, n = 173) between 1.5 and 12 years of age were enrolled in a prospective cohort study. Kidney Disease: Improving Global Outcomes (KDIGO) criteria were used to retrospectively define AKI and chronic kidney disease (CKD). Cognitive testing was conducted using the Mullen Scales of Early Learning in children < 5 and Kaufman Assessment Battery for Children (K-ABC) second edition in children ≥ 5 years of age. RESULTS: The prevalence of AKI was 35.1%, ranging from 25.1% in SMA to 43.5% in CM. In-hospital mortality was 11.9% in AKI compared to 4.2% in children without AKI (p = 0.001), and post-discharge mortality was 4.7% in AKI compared to 1.3% in children without AKI (p = 0.030) corresponding to an all-cause adjusted hazard ratio of 2.30 (95% CI 1.21, 4.35). AKI was a risk factor for short- and long-term neurocognitive impairment. At 1 week post-discharge, the frequency of neurocognitive impairment was 37.3% in AKI compared to 13.5% in children without AKI (adjusted odds ratio (aOR) 2.31 [95% CI 1.32, 4.04]); at 1-year follow-up, it was 13.3% in AKI compared to 3.4% in children without AKI (aOR 2.48 [95% CI 1.01, 6.10]), and at 2-year follow-up, it was 13.0% in AKI compared to 3.4% in children without AKI (aOR 3.03 [95% CI 1.22, 7.58]). AKI was a risk factor for CKD at 1-year follow-up: 7.6% of children with severe malaria-associated AKI had CKD at follow-up compared to 2.8% of children without AKI (p = 0.038) corresponding to an OR of 2.81 (95% CI 1.02, 7.73). The presenting etiology of AKI was consistent with prerenal azotemia, and lactate dehydrogenase as a marker of intravascular hemolysis was an independent risk factor for AKI in CM and SMA (p < 0.0001). In CM, AKI was associated with the presence and severity of retinopathy (p < 0.05) and increased cerebrospinal fluid albumin suggestive of blood-brain barrier disruption. CONCLUSIONS: AKI is a risk factor for long-term neurocognitive impairment and CKD in pediatric severe malaria.

KW - Acute kidney injury

KW - Child

KW - Chronic kidney disease

KW - Cognition

KW - Malaria

KW - Mortality

UR - http://www.scopus.com/inward/record.url?scp=85066454311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066454311&partnerID=8YFLogxK

U2 - 10.1186/s12916-019-1332-7

DO - 10.1186/s12916-019-1332-7

M3 - Article

VL - 17

JO - BMC Medicine

JF - BMC Medicine

SN - 1741-7015

IS - 1

ER -